JRCT ID: jRCTs021180004
Registered date:13/03/2019
Effectiveness of BBG
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Cataract, Vitreoretinal diseases |
Date of first enrollment | 11/11/2013 |
Target sample size | 220 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Intracameral or intravitreal injection of Brilliant blue G |
Outcome(s)
Primary Outcome | Visual acuity |
---|---|
Secondary Outcome | Retinal morphological changes measured byoOptical coherence tomography (OCT) |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Needs of use of Brilliant blue G in cataract or vitreous surgery |
Exclude criteria | Without severe ocular infections |
Related Information
Primary Sponsor | Abe Samae |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Sanae Abe |
Address | Hondo 1-1-1, Akita 010-8543, Japan Akita Japan 010-8543 |
Telephone | +81-18-884-6167 |
sanaeabe@med.akita-u.ac.jp | |
Affiliation | Akita University Hospital |
Scientific contact | |
Name | Samae Abe |
Address | Hondo 1-1-1, Akita 010-8543, Japan Akita Japan 010-8543 |
Telephone | +81-18-884-6167 |
sanaeabe@med.akita-u.ac.jp | |
Affiliation | Akita University Hospital |